NAMS MENOPAUSE CERTIFICATION EXAM –
COMPREHENSIVE PRACTICE
(2026/2027 EDITION)
The Menopause Society (formerly NAMS) • MSCP Examination Preparation
120 Four-Option Questions • Extended Practice Format
Official 2026 MSCP examination: 100 questions, 3 response alternatives, 2-hour limit
Current-reference basis: 2026 MSCP Candidate Handbook; Society HT, nonhormone, GSM, and
osteoporosis guidance; current U.S. prescribing information through 2026
Independent educational material — not an official MSCP examination.
Clinical decisions require current product labeling, local guidance, and individualized
professional judgment.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 1 of 33
,MSCP PRACTICE EXAM • 120 QUESTIONS
Section 1: Physiology & Pathophysiology of Menopause Transition –
Terminology, STRAW+10, Endocrinology (25 questions)
Q1: How is natural menopause clinically defined?
A. The final menstrual period, recognized retrospectively after 12 consecutive months of amenorrhea without
another cause [CORRECT]
B. Any six-month interval without bleeding
C. The first irregular menstrual cycle after age 40
D. A single elevated FSH measurement
Correct Answer: A
Rationale: Natural menopause is confirmed retrospectively after 12 months without menstruation when no other
pathologic or physiologic cause explains the amenorrhea. Six months, cycle irregularity, or one FSH value does not
establish the diagnosis.
Q2: What does the term climacteric describe?
A. The broader endocrinologic, somatic, and psychosocial transition surrounding the end of reproductive life
[CORRECT]
B. Only the date of the final menstrual period
C. Only the first year after menopause
D. A synonym for primary ovarian insufficiency
Correct Answer: A
Rationale: The climacteric encompasses the broader transition and associated changes around menopause. It is
not a single date, a one-year interval, or synonymous with POI.
Q3: Under STRAW+10, what bleeding criterion marks entry into early menopausal transition, Stage -2?
A. A persistent difference of at least 7 days in the length of consecutive cycles, recurring within 10 cycles
[CORRECT]
B. At least 30 days of amenorrhea
C. At least 60 consecutive days of amenorrhea
D. Twelve months of amenorrhea
Correct Answer: A
Rationale: Stage -2 begins with persistent cycle-length variability of at least 7 days. Sixty days marks Stage -1,
and 12 months confirms the final menstrual period retrospectively.
Q4: Under STRAW+10, what menstrual pattern defines late menopausal transition, Stage -1?
A. Cycles differing by exactly 3 days
B. Twelve consecutive months without bleeding
C. An interval of amenorrhea lasting at least 60 consecutive days [CORRECT]
D. Regular cycles with normal ovarian reserve
Correct Answer: C
Rationale: A 60-day or longer episode of amenorrhea is the principal bleeding criterion for Stage -1. Smaller
variability, 12-month amenorrhea, and regular cycles describe other stages or conditions.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 2 of 33
,MSCP PRACTICE EXAM • 120 QUESTIONS
Q5: What period is represented by STRAW+10 Stage +1a?
A. The second year after the final menstrual period
B. The first 12 months after the final menstrual period [CORRECT]
C. Years 3 through 8 after the final menstrual period
D. The entire remaining lifespan
Correct Answer: B
Rationale: Stage +1a is the first post-FMP year and ends when 12 months of amenorrhea confirms menopause.
The second year is +1b, later early postmenopause is +1c, and the remaining lifespan is +2.
Q6: Which statement best describes STRAW+10 Stage +2?
A. It is the 60-day amenorrhea interval before the final menstrual period
B. It follows early postmenopause and lasts for the remaining lifespan, when somatic aging predominates
[CORRECT]
C. It is limited to the second year after the final menstrual period
D. It is defined by high fertility and regular ovulation
Correct Answer: B
Rationale: Stage +2 is late postmenopause after Stage +1c and continues for the rest of life. The alternatives
describe Stage -1, Stage +1b, or reproductive life.
Q7: A 47-year-old has cycles of 25, 34, 26, and 35 days, with the variability recurring over six cycles.
Which STRAW+10 stage best fits?
A. Stage -1, late menopausal transition
B. Stage -2, early menopausal transition [CORRECT]
C. Stage +1a, early postmenopause
D. Stage +2, late postmenopause
Correct Answer: B
Rationale: Repeated cycle-length differences of at least 7 days support Stage -2. She has neither a 60-day
amenorrhea interval nor a documented final menstrual period.
Q8: A 51-year-old previously had variable cycles and now has had no bleeding for 72 days. Which stage
is most likely?
A. Stage -2, early menopausal transition
B. Stage +1a, confirmed menopause
C. Stage -1, late menopausal transition [CORRECT]
D. Stage +2, late postmenopause
Correct Answer: C
Rationale: Amenorrhea of 60 days or longer places her in Stage -1. Menopause is not confirmed until 12 months
after the final menstrual period, so postmenopausal stages are premature.
Q9: A patient is 14 months beyond her final menstrual period. Which STRAW+10 substage best fits?
A. Stage -1
B. Stage +1a
C. Stage +2
D. Stage +1b [CORRECT]
Correct Answer: D
Rationale: Stage +1a covers the first 12 months after the FMP, and +1b covers the next year. Stage -1 precedes
the FMP, while +2 follows completion of early postmenopause.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 3 of 33
, MSCP PRACTICE EXAM • 120 QUESTIONS
Q10: A patient is four years beyond her final menstrual period, with stable high FSH and low estradiol.
Which stage best fits?
A. Stage -2
B. Stage +1c [CORRECT]
C. Stage +1a
D. Stage +2
Correct Answer: B
Rationale: Stage +1c is the later portion of early postmenopause, lasting approximately 3 to 6 years after +1a
and +1b. The other stages occur before the FMP, in its first year, or after early postmenopause.
Q11: A 63-year-old is 11 years beyond her final menstrual period. Which STRAW+10 stage is most
likely?
A. Stage -2
B. Stage +2, late postmenopause [CORRECT]
C. Stage -1
D. Stage +1a
Correct Answer: B
Rationale: Eleven years after the FMP is well beyond the 5-to-8-year span of early postmenopause and fits Stage
+2. Stages -2 and -1 precede the FMP, and +1a is only the first year after it.
Q12: A 45-year-old still cycles regularly, but early-follicular FSH is intermittently elevated as ovarian
follicle number declines. What mechanism best explains the FSH rise?
A. Persistent excess progesterone from the corpus luteum
B. Increased AMH secretion from granulosa cells
C. Reduced inhibin B feedback from the shrinking follicle pool [CORRECT]
D. Suppression of pituitary gonadotropins by low estradiol
Correct Answer: C
Rationale: Declining inhibin B reduces negative feedback and permits a monotropic FSH rise. AMH also declines,
progesterone is not persistently excessive, and reduced rather than increased pituitary suppression is occurring.
Q13: A 49-year-old with irregular cycles has estradiol and FSH values that vary widely from month to
month. What is the best interpretation?
A. One normal FSH excludes the menopausal transition
B. One high estradiol level proves an estrogen-secreting tumor
C. The final menstrual period can be dated precisely from a single laboratory panel
D. Hormone fluctuation is expected in the transition, so menstrual history and clinical context are more useful
than one measurement [CORRECT]
Correct Answer: D
Rationale: FSH and estradiol can fluctuate markedly, with estradiol occasionally reaching high levels, so a single
panel is often misleading. It neither excludes transition nor precisely predicts the FMP, and tumor evaluation
requires the broader clinical picture.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 4 of 33
COMPREHENSIVE PRACTICE
(2026/2027 EDITION)
The Menopause Society (formerly NAMS) • MSCP Examination Preparation
120 Four-Option Questions • Extended Practice Format
Official 2026 MSCP examination: 100 questions, 3 response alternatives, 2-hour limit
Current-reference basis: 2026 MSCP Candidate Handbook; Society HT, nonhormone, GSM, and
osteoporosis guidance; current U.S. prescribing information through 2026
Independent educational material — not an official MSCP examination.
Clinical decisions require current product labeling, local guidance, and individualized
professional judgment.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 1 of 33
,MSCP PRACTICE EXAM • 120 QUESTIONS
Section 1: Physiology & Pathophysiology of Menopause Transition –
Terminology, STRAW+10, Endocrinology (25 questions)
Q1: How is natural menopause clinically defined?
A. The final menstrual period, recognized retrospectively after 12 consecutive months of amenorrhea without
another cause [CORRECT]
B. Any six-month interval without bleeding
C. The first irregular menstrual cycle after age 40
D. A single elevated FSH measurement
Correct Answer: A
Rationale: Natural menopause is confirmed retrospectively after 12 months without menstruation when no other
pathologic or physiologic cause explains the amenorrhea. Six months, cycle irregularity, or one FSH value does not
establish the diagnosis.
Q2: What does the term climacteric describe?
A. The broader endocrinologic, somatic, and psychosocial transition surrounding the end of reproductive life
[CORRECT]
B. Only the date of the final menstrual period
C. Only the first year after menopause
D. A synonym for primary ovarian insufficiency
Correct Answer: A
Rationale: The climacteric encompasses the broader transition and associated changes around menopause. It is
not a single date, a one-year interval, or synonymous with POI.
Q3: Under STRAW+10, what bleeding criterion marks entry into early menopausal transition, Stage -2?
A. A persistent difference of at least 7 days in the length of consecutive cycles, recurring within 10 cycles
[CORRECT]
B. At least 30 days of amenorrhea
C. At least 60 consecutive days of amenorrhea
D. Twelve months of amenorrhea
Correct Answer: A
Rationale: Stage -2 begins with persistent cycle-length variability of at least 7 days. Sixty days marks Stage -1,
and 12 months confirms the final menstrual period retrospectively.
Q4: Under STRAW+10, what menstrual pattern defines late menopausal transition, Stage -1?
A. Cycles differing by exactly 3 days
B. Twelve consecutive months without bleeding
C. An interval of amenorrhea lasting at least 60 consecutive days [CORRECT]
D. Regular cycles with normal ovarian reserve
Correct Answer: C
Rationale: A 60-day or longer episode of amenorrhea is the principal bleeding criterion for Stage -1. Smaller
variability, 12-month amenorrhea, and regular cycles describe other stages or conditions.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 2 of 33
,MSCP PRACTICE EXAM • 120 QUESTIONS
Q5: What period is represented by STRAW+10 Stage +1a?
A. The second year after the final menstrual period
B. The first 12 months after the final menstrual period [CORRECT]
C. Years 3 through 8 after the final menstrual period
D. The entire remaining lifespan
Correct Answer: B
Rationale: Stage +1a is the first post-FMP year and ends when 12 months of amenorrhea confirms menopause.
The second year is +1b, later early postmenopause is +1c, and the remaining lifespan is +2.
Q6: Which statement best describes STRAW+10 Stage +2?
A. It is the 60-day amenorrhea interval before the final menstrual period
B. It follows early postmenopause and lasts for the remaining lifespan, when somatic aging predominates
[CORRECT]
C. It is limited to the second year after the final menstrual period
D. It is defined by high fertility and regular ovulation
Correct Answer: B
Rationale: Stage +2 is late postmenopause after Stage +1c and continues for the rest of life. The alternatives
describe Stage -1, Stage +1b, or reproductive life.
Q7: A 47-year-old has cycles of 25, 34, 26, and 35 days, with the variability recurring over six cycles.
Which STRAW+10 stage best fits?
A. Stage -1, late menopausal transition
B. Stage -2, early menopausal transition [CORRECT]
C. Stage +1a, early postmenopause
D. Stage +2, late postmenopause
Correct Answer: B
Rationale: Repeated cycle-length differences of at least 7 days support Stage -2. She has neither a 60-day
amenorrhea interval nor a documented final menstrual period.
Q8: A 51-year-old previously had variable cycles and now has had no bleeding for 72 days. Which stage
is most likely?
A. Stage -2, early menopausal transition
B. Stage +1a, confirmed menopause
C. Stage -1, late menopausal transition [CORRECT]
D. Stage +2, late postmenopause
Correct Answer: C
Rationale: Amenorrhea of 60 days or longer places her in Stage -1. Menopause is not confirmed until 12 months
after the final menstrual period, so postmenopausal stages are premature.
Q9: A patient is 14 months beyond her final menstrual period. Which STRAW+10 substage best fits?
A. Stage -1
B. Stage +1a
C. Stage +2
D. Stage +1b [CORRECT]
Correct Answer: D
Rationale: Stage +1a covers the first 12 months after the FMP, and +1b covers the next year. Stage -1 precedes
the FMP, while +2 follows completion of early postmenopause.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 3 of 33
, MSCP PRACTICE EXAM • 120 QUESTIONS
Q10: A patient is four years beyond her final menstrual period, with stable high FSH and low estradiol.
Which stage best fits?
A. Stage -2
B. Stage +1c [CORRECT]
C. Stage +1a
D. Stage +2
Correct Answer: B
Rationale: Stage +1c is the later portion of early postmenopause, lasting approximately 3 to 6 years after +1a
and +1b. The other stages occur before the FMP, in its first year, or after early postmenopause.
Q11: A 63-year-old is 11 years beyond her final menstrual period. Which STRAW+10 stage is most
likely?
A. Stage -2
B. Stage +2, late postmenopause [CORRECT]
C. Stage -1
D. Stage +1a
Correct Answer: B
Rationale: Eleven years after the FMP is well beyond the 5-to-8-year span of early postmenopause and fits Stage
+2. Stages -2 and -1 precede the FMP, and +1a is only the first year after it.
Q12: A 45-year-old still cycles regularly, but early-follicular FSH is intermittently elevated as ovarian
follicle number declines. What mechanism best explains the FSH rise?
A. Persistent excess progesterone from the corpus luteum
B. Increased AMH secretion from granulosa cells
C. Reduced inhibin B feedback from the shrinking follicle pool [CORRECT]
D. Suppression of pituitary gonadotropins by low estradiol
Correct Answer: C
Rationale: Declining inhibin B reduces negative feedback and permits a monotropic FSH rise. AMH also declines,
progesterone is not persistently excessive, and reduced rather than increased pituitary suppression is occurring.
Q13: A 49-year-old with irregular cycles has estradiol and FSH values that vary widely from month to
month. What is the best interpretation?
A. One normal FSH excludes the menopausal transition
B. One high estradiol level proves an estrogen-secreting tumor
C. The final menstrual period can be dated precisely from a single laboratory panel
D. Hormone fluctuation is expected in the transition, so menstrual history and clinical context are more useful
than one measurement [CORRECT]
Correct Answer: D
Rationale: FSH and estradiol can fluctuate markedly, with estradiol occasionally reaching high levels, so a single
panel is often misleading. It neither excludes transition nor precisely predicts the FMP, and tumor evaluation
requires the broader clinical picture.
NAMS Menopause Certification Exam – Comprehensive Practice (2026/2027) Page 4 of 33
